SHILPA MEDICARE LTD. - 530549 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In pursuance to the provisions of SEBI (Listing obligations & Disclosure Requirements) Regulation, 2015 Please find herewith the copy of Annual Secretarial Compliance Report for the Financial Year ended 31 March 2022. We hereby request you to kindly take the same on record. SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window
With reference to the above subject, we would like to inform you that pursuant to Code of Conduct for Regulating, Monitoring and Reporting Trading by Designated Persons and their Immediate Relatives, the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives as covered under the said Code with effect from 1st July, 2022 till 48 hours after the declaration of Un-audited Financial Results of the Company for the quarter ended 30" June, 2022. Please note that the date of the Board Meeting to be held for the consideration of Un-audited Financial Results of the Company for the quarter ended 30* June, 2022 shall be communicated in due course of time. This is for your information and records. SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copies of newspaper advertisement published in Suddimoola (Kannada) and Business Line (English) regarding intimation of transfer of unclaimed dividends and equity shares of the Company for the Financial Year 2014-2015 to Investor Education and Protection Fund (IEPF) after the due date pursuant to the provisions of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. SHILPA MEDICARE LTD. - 530549 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March 2022
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Disclosure of Related Party Transactions on a consolidated basis, for the period from 01st October 2021 to 31st March 2022 in the prescribed format (as specified by SEBI). SHILPA MEDICARE LTD. - 530549 - Scrutinizer Report For NCLT Convened Secured Creditors Meeting - U/R 30 Of The SEBI(LODR) Regulations, 2015
Scrutinizer's Report dated 30th May 2022 for the Secured Creditors meeting of Shilpa Medicare Limited convened by the Hon'ble National Company Law Tribunal ('NCLT'), Bengaluru Bench held on Friday the 27th day of May 2022 at 1.00 p.m. through Video Conference ('VC')/ Other Audio-Visual Means ('OAVM') at 'Shilpa House', # 12-6-214/A-1, Hyderabad road, Raichur - 584 135, Karnataka and concluded at 1.15 p.m. for the purpose of sanctioning the Scheme of Amalgamation between INM Technologies Private Limited (Transferor Company) and Shilpa Medicare Limited (Transferee Company). SHILPA MEDICARE LTD. - 530549 - Scrutinizer Report For NCLT Convened Trade Creditors Meeting - U/R 30 Of The SEBI(LODR) Regulations, 2015
Scrutinizer's Report dated 30th May 2022 for the Trade Creditors meeting of Shilpa Medicare Limited convened by the Hon'ble National Company Law Tribunal ('NCLT'), Bengaluru Bench held on Friday the 27th day of May 2022 at 11.00 a.m. through Video Conference ('VC')/ Other Audio-Visual Means ('OAVM') at 'Shilpa House', # 12-6-214/A-1, Hyderabad road, Raichur - 584 135, Karnataka for the purpose of sanctioning the Scheme of Amalgamation between INM Technologies Private Limited (Transferor Company) and Shilpa Medicare Limited (Transferee Company). SHILPA MEDICARE LTD. - 530549 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Shilpa Medicare Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SHILPA MEDICARE LTD. - 530549 - Scrutinizer Report For NCLT Convened Equity Shareholders Meeting - U/R 44 Of The SEBI(LODR) Regulations, 2015.
Please find enclosed the Scrutinizer's Report dated 30" May 2022 for the Equity Shareholders meeting of Shilpa Medicare Limited convened by the Hon'ble National Company Law Tribunal ('NCLT'), Bengaluru Bench held on Friday the 27th day of May 2022 at 9.00 a.m. through Video Conference ('VC')/ Other Audio-Visual Means ('OAVM') at 'Shilpa House', # 12-6-214/A-1, Hyderabad road, Raichur - 584 135, Karnataka for the purpose of sanctioning the Scheme of Amalgamation between INM Technologies Private Limited (Transferor Company) and Shilpa Medicare Limited (Transferee Company). SHILPA MEDICARE LTD. - 530549 - Proceedings Of NCLT Convened Meeting Of Equity Shareholders, Trade Creditors And Secured Creditors
In reference to the captioned subject, we hereby wish to inform that the NCLT Convened Meeting of the Equity Shareholders, Trade Creditors and Secured Creditors of Shilpa Medicare Limited on 27 May 2022. please find herewith the enclosed summary of the proceedings of meeting of the Equity Shareholders, Trade Creditors and Secured Creditors of the Company convened as per the directions of NCLT as Annexures I, II and III respectively. SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for the quarter and year ended 31 March 2022